Anaerobic glycolysis protection against 1-methy-4-phenylpyridinium (MPP+) toxicity in C6 glioma cells

Neurochemical Research

Volumn 32, Issue 6, 2007, Pages 1071-1080

  Williams, Zakia R ^a   Goodman, Carl B ^a   Soliman, Karam F A ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

ATP; Energy; Glioma cells; Membrane potential; Mitochondria; MPP+

Indexed keywords

1 METHY 4 PHENYLPYRIDINIUM; ADENOSINE TRIPHOSPHATE; FLUORESCEIN DIACETATE; GLUCOSE; PYRIDINIUM DERIVATIVE; RHODAMINE 123; UNCLASSIFIED DRUG;

ANAEROBIC GLYCOLYSIS; ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FLUORESCENCE ANALYSIS; FLUOROMETRY; GLIOMA CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; SUPPLEMENTATION;

1-METHYL-4-PHENYLPYRIDINIUM; ADENOSINE TRIPHOSPHATE; ANAEROBIOSIS; ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; CYTOPLASM; DOPAMINE AGENTS; FLUORESCEIN; FLUORESCENT DYES; GLIOMA; GLUCOSE; GLYCOLYSIS; IN SITU NICK-END LABELING; LUMINESCENCE; MEMBRANE POTENTIALS; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA; RATS;

EID: 34248181508     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-006-9276-7     Document Type: Article

References (36)

1. Blum D, Torch S, Lambeng N, Nissou M-F, Benabid A-L, Sadoul R, Verna J-M (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine, and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 65:135-172
2. Nicklas WJ, Vyas I, Heikkila RE (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. Life Sci 36:2503-2508
3. Ramsay RE, Singer RP (1986) Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine by mitochondria. J Biol Chem 75:85-7587
4. +) cytotoxicity. Biochem Biophys Res Commun 137:303-309
5. Denton T, Howard BD (1987) A dopaminergic cell line resistant to the neurotoxin. 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. J Neurochem 49:622-630
6. Chan P, DeLanney LS, Irwin I, Langston JW, Di Monte D (1984) Rapid ATP loss caused by of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain. J Neurochem 57:348-351
7. Scotcher KP, Irwin I, DeLanney LE, Langston JW, Di Monte D (1990) Effects of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine and 1-methyl-4- phenylpyridinium ion on ATP levels of mouse synaptosomes. J Neurochem 54:1295-1301
8. Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39:889-909
9. Smith MT, Ekstrom G, Sandy MS, Di Monte D (1987) Studies on the mechanism of cytotoxicity in isolated hepatocytes. Life Sci 40:741-748
10. Mizuno Y, Saitoh T, Sone N (1987) Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity by 1-methylphenylpyridinium ion. Biochem Biophys Res Commun 143:294-299
11. Chan P, DeLanney LS, Irwin I, Langston JW, Di Monte D (1991) Rapid ATP loss caused by of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain. J Neurochem 57:348-351
12. Di Monte DA, Wu EY, Irwin I, Delanney LE, Langston JW (1991) Biotransformation of in primary cultures of mouse astrocytes. J Pharmacol Exp Ther 258:594-600
13. Bates TE, Heales SJ, Davies SE, Boakye P, Clark JB (1994) Effects of 1-methyl-4-phenylpyridinium on isolated rat brain mitochondria: evidence for a primary involvement of energy depletion. J Neurochem 63:640-648
14. Forno LS, Delanny LE, Irwin I, Di Monte D, Langston JW (1992) Astrocytes and Parkinson's disease. Prog Brain Res 94:429-436
15. Chiba K, Trevor A, Castagnoli N Jr (1984) Metabolism of the neurotoxic tertiary amine, MPTP, by brain oxidase. Biochem Biophy Res Comm 120:574-578
16. +): identification of a metabolite of MPTP, a toxin selective to the substantia nigra. Neurosci Lett 48:87-92
17. Ransom BR, Kunis DM, Irwin I, Langston JW (1987) Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+. Neurosci Lett 75:323-328
18. +. J Neural Transm 76:1-12
19. Wu EY, Langston JW, Di Monte DA (1992) Toxicity of the 1-methyl-2, 3-dihydtopyridinium and 1-methyl-4-phenylpryidinium species in primary cultures of mouse astrocyte. J Pharmacol Exp Ther 62:2259-2230
20. Mazzio E, Soliman K (2003) The role of glycolysis and gluconeogenesis in the cytoprotection of neuroblastoma cells against 1-methyl-3-phenyl-pyridinium ion toxicity. Neurotoxicology 24:137-147
21. Di Monte DA, Wu EY, Delanney Irwin I, Langston JW (1992) Toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes. J Pharmacol Exp Ther 261:144-149
22. Marcelo MN, Assaf S, Petros B, Carlo R (1998) A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity. J Immunological Methods 213:157-167
23. Youngster SK, Sonsalla PK, Heikkila RE (1987) Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. J Neurochem 48:989-934
24. Basma AN, Heikkila RE, Nicklas WJ, Giovanni A, Geller HM (1990) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4- (2'-ethylphenyl)-1,2,3,6- tetrahydropyridine induced toxicity in PC12 cells: role of monoamine oxidase A. J Neurochem 55:870-877
25. Chamlmers-Redman RM, MacLean Fraser AD, Carlile GW, Pong A, Tatton WG (1999) Glucose protection from MPP-induced apoptosis depends on mitochondrial membrane potential and ATP synthase. Biochem Biophy Res Comm 257:440-447
26. Hertz L, Yager JY, Juurlink BHJ (1995) Astrocyte survival in the absence of exogenous substrate: comparison of immature and mature cells. Int J Dev Neurosci 13:523-527
27. Hassouna I, Wickert H, Zimmermann M, Gillardon F (1996) Increase in bax expression in substantia nigra following 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) treatment of mice. Neurosci Lett 204:85-88
28. Tatton NA, Kish SJ (1997) In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine- treated mice using terminal deoxynucleotidyl transferase labeling and Acridine Orange staining. Neuroscience 77:1037-1048
29. Eberhardt O, von Coelln R, Kügler S, Lindenau J, Rathke-Hartlieb S, Gerhardt E, Haid S, Isenmann S, Gravel C, Srinivasan A, Weller M, Bähr M, Dichgans J, Schulz JB (2000) Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine model of Parkinson's disease. J Neurosci 20:9126-9134
30. Turmel H, Hartmann A, Parain K, Douhou A, Srinivasan A, Agid Y, Hirsch EC Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Mov Disorders 16:185-189
31. Viswanath V, Wu Y, Boonplueang R, Chen S, Stevenson FF, Yantiri F, Yang L, Beal MF, Andersen JK (2001) Caspase-9 activation results in downstream caspase activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced Parkinson's disease. J Neurosci 21:9519-9528
32. +) causes DNA fragmentation and increases the Bcl-2 expression in human neuroblastoma, SH-SY5Y cells through different mechanisms. Brain Res 704:240-245
33. + induced apoptotic cell death in SH-SY5Y neuroblastoma cells: an electron microscope study. J Neurosci Res 48:226-237
34. Dipasquale B, Marini AM, Youle RJ (1991) Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons. Biochem Biophys Res Comm 181:1442-1448
35. Du Y, Dodel RC, Bales KR, Jemmersom R, Hamilton- Byrd E, Paul SM (1997) Involvement of a caspase-3-like cysteine protease in 1-methyl-4- phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons. J Neurochem 69:1382-1388
36. +) in ventral mesencephalic-striatal co-culture in rat. Neurosci Lett 170:191-194